< 生产厂家价格 >

对甲氧基肉桂酸辛酯

对甲氧基肉桂酸辛酯用途

Octinoxate是有机化合物, 是防晒霜和唇膏的组成成分, 主要用在防晒霜等化妆品中, 吸收来自太阳的UV-B射线, 保护皮肤免受损伤, 也可用于减少疤痕的外观。

点击显示

对甲氧基肉桂酸辛酯名称

[ CAS 号 ]:
5466-77-3

[ 中文名 ]:
对甲氧基肉桂酸辛酯

[ 英文名 ]:
Octyl 4-methoxycinnamate

[中文别名 ]:

[英文别名 ]:

Escalol 557
Eusolex 2292
Neo Heliopan AV
2-ethylhexyl (E)-3-(4-methoxyphenyl)prop-2-enoate
2-Ethylhexyl (2E)-3-(4-methoxyphenyl)acrylate
octinoxate
2-Ethylhexyl trans-4-methoxycinnamate
Octyl p-Methoxycinnamate
Uvinul MC 80
octyl methoxycinnamate

对甲氧基肉桂酸辛酯生物活性

[ 描述 ]:

[ 相关类别 ]:

信号通路 >> 其他 >> 其他

研究领域 >> 其他

[相关活性小分子]

对甲氧基肉桂酸辛酯物理化学性质

[ 密度 ]:
1.0±0.1 g/cm3

[ 沸点 ]:
405.3±20.0 °C at 760 mmHg

[ 分子式 ]:
C₁₈H₂₆O₃

[ 分子量 ]:
290.397

[ 闪点 ]:
171.6±16.4 °C

[ 精确质量 ]:
290.188202

[ PSA ]:
35.53000

[ LogP ]:
5.66

[ 外观性状 ]:
无色或淡黄色液体

[ 蒸汽压 ]:
0.0±0.9 mmHg at 25°C

[ 折射率 ]:
1.515

[ 储存条件 ]:
2-8°C

[ 稳定性 ]:
Stable. Incompatible with strong oxidizing agents.

[ 水溶解性 ]:
<0.1 g/100 mL at 27 ºC

对甲氧基肉桂酸辛酯MSDS

详细MSDS(安全技术说明书)

对甲氧基肉桂酸辛酯安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xi

[ 安全声明 (欧洲) ]:
S24/25

[ 危险品运输编码 ]:
NONH for all modes of transport

[ RTECS号 ]:
UD3392732

[ 海关编码 ]:
2918990090

对甲氧基肉桂酸辛酯合成路线

详细合成路线

对甲氧基肉桂酸辛酯上下游产品

对甲氧基肉桂酸辛酯上游产品

对甲氧基肉桂酸辛酯下游产品

对甲氧基肉桂酸辛酯制备

1.将对甲苯磺酸加入辛醇和茴香醛、丙二酸、吡啶的混合物中，进行酯化反应后，中和、脱水、恒沸蒸馏，精制而得该品。

点击显示

对甲氧基肉桂酸辛酯海关

[ 海关编码 ]: 2918990090

[ 中文概述 ]:
2918990090. 其他含其他附加含氧基羧酸（包括酸酐、酰卤化物、过氧化物和过氧酸及该税号的衍生物）. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

对甲氧基肉桂酸辛酯文献

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

J. Sci. Ind. Res. 65(10) , 808, (2006)

Drug-induced liver injury (DILI) is a significant concern in drug development due to the poor concordance between preclinical and clinical findings of liver toxicity. We hypothesized that the DILI typ...

Developing structure-activity relationships for the prediction of hepatotoxicity.

Chem. Res. Toxicol. 23 , 1215-22, (2010)

Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ...

A predictive ligand-based Bayesian model for human drug-induced liver injury.

Drug Metab. Dispos. 38 , 2302-8, (2010)

Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predicti...

更多文献